The Latest in The Journal of Community and Supportive Oncology

Biosimilars poised to save $54 billion over the next decade

October 25, 2017

Onodera’s Prognostic Nutritional Index in soft tissue sarcoma patients as a predictor of wound complications

October 5, 2017

David Henry's JCSO podcast, September-October 2017

October 1, 2017

Two cases of possible remission in metastatic triple-negative breast cancer

September 28, 2017

Bone remodeling associated with CTLA-4 inhibition: an unreported side effect

September 8, 2017

Management of polycythemia vera in the community oncology setting

September 8, 2017

Patient & Survivor Care

Assessing a multidisciplinary survivorship program in a group of predominantly Hispanic women with breast cancer

September 8, 2017

Goals-of-care discussions

September 8, 2017

Patient & Survivor Care

An ASCO 2017 recap: significant advances continue

September 8, 2017

‘Making a difference in cancer care’

September 7, 2017

Patient & Survivor Care

Management of high-grade pleomorphic sarcoma with colon metastasis

September 7, 2017

Intramedullary spinal cord and leptomeningeal metastases presenting as cauda equina syndrome in a patient with melanoma

September 7, 2017

Evidence-based information for the entire oncology care team

September 7, 2017

Business of Medicine

Ribociclib: another CDK inhibitor hits the mark in breast cancer

August 20, 2017

Breast Cancer

Approval makes olaratumab the first first-line treatment option for soft tissue sarcoma in more than 40 years

August 20, 2017

Sarcoma & GIST